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Abstract
Today dementia certainly represents a
public health priority with a huge global
impact on wordwide population. However,
clinical and social issues related to demen-
tia have long been marginalized. The actual
high prevalence of dementias requires also
to face issues from a bioethical perspective,
regarding how to deal with demented
patient’s disposition.
There are currently no specific guide-
lines on the national territory regarding
whether to draw up a living will by a patient
with dementia, neither about the informa-
tive role of physicians during the progres-
sive story of the disease.
Introduction
In 2015 more than 46 million people
were affected by dementia. This amount is
estimated to almost double every 20 years,
increasing to 131.5 million by 2050.1
Alzheimer’s disease (AD) is the most com-
mon form of dementia and it possibly con-
tributes to 60-70% of cases. In 2006 the
worldwide prevalence of AD was indicated
in 26.6 million. It was also estimated that
this number would quadruple by 2050, so
that 1 out 85 subjects would be living with
the disease.2
These numbers well point out how
today dementia certainly represents a public
health priority with a huge global impact on
wordwide population.
However, clinical and social issues
related to dementia - especially to AD -
have long been marginalized by the interna-
tional scientific community and society in
general. Dementia was often configured as
integral part of aging or rather a taboo sub-
ject. Moreover, the absence of a cure, net of
symptomatic therapies currently in use, has
certainly played a decisive role, which has
led to simply conceive dementia as an
inescapable destiny. We should not forget
that dementia, by definition,3 is a syndrome
caused by a number of progressive illnesses
that affects on different levels cognitive
functions, behavior and the ability to inde-
pendently perform everyday activities. 
In this context, the risk is to receive a
diagnosis of dementia only at an advanced
stage, often when even behavioral and psy-
chological symptoms are already exacerbat-
ed and the burden both for patient and care-
giver has increased. 
The actual high prevalence of demen-
tias (especially AD) requires to face with
new problems and to decide as well on
issues for which there are no immediate
answers. It is especially difficult for family
members and caregivers who often have to
make these decisions on behalf of the
patient. As a matter of fact, subjects with
dementia, compared for example to patients
affected by different medical conditions,
likely have little space to express their will,
due to the progressive cognitive impairment
which makes them less and less aware of
their pathological status.
Discussion
From a bioethical perspective, self-
determination clearly represents a cardinal
principle in the doctor/patient relationship.
The question of self-determination in sub-
jects with dementia is actually an area of
debate.4 While, according to the law, the
right to self-determination of every adult
citizen must be respected, on the other side
cognitive disabilities progressively affect
their capacity to make decisions.5
A widely accepted definition of deci-
sion-making capacity6 is based on the fol-
lowing strongholds. The patient should: i)
understand relevant information on the
treatment, including the risks and the bene-
fits; ii) be able to assess the situation and its
consequences; iii) be able to evaluate the
different therapeutic alternatives; iv) know
how to communicate a choice.
Generally to evaluate these skills two
different approaches can be taken in
account: to create ad hoc tools (question-
naires and interviews) or to adapt neuropsy-
chological test batteries normally used in
the assessment of cognitive impairment.7 A
proper evaluation, indeed, should not leave
aside those cognitive functions known as
executive functions, involved in several
aspects of daily life. Neuropsychological
tests of complex abilities such as attention,
memory, frontal functions, language and
visuospatial abilities should be incorporated
into capacity assessments.
Moreover a deep psychopathological
assessment it is also crucial to exclude the
presence of a psychiatric condition or per-
sonality disorder which could affect sub-
ject’s self determination.
In the precise order to respect the
patient’s right to self-determination, scien-
tific community and international politics
have recently begun to discuss the proposal
for a living will even to subjects with
dementia. This will basically configures the
possibility to decide before being no longer
able to do so and its use is well known espe-
cially in cases of euthanasia.
In this context, living will appears to be
one of the most suitable instruments to
ensure greater respect for the will of a
demented patient along his disease’s pro-
gression. However, as previously pointed,
dementia is a story that is written over many
years (on average, ten) during which is
gradually established an inability to make
even the most basic decisions of daily life. 
It is therefore necessary to evaluate
when a living will should be proposed to a
patient who has been taken in care for cog-
nitive impairment (Figure 1). It could be a
proper choice by the physician to discuss
this opportunity early in the disease, when
the subject is still able to understand and
perhaps make plans. 
It should also be remembered that pre-
cisely in the early stages of the disease the
patient appears to be more vulnerable, due
to several changes he/she is experiencing
which involve his/her cognition and gener-
ate a real psychological burden. It would be
strongly recommended a specific work on
the disease awareness in order to make wise
and weighted decisions about the future. In
this context could play a key role not only
the quality of the doctor/patient relation-
ship, but also a correct diagnosis disclosure
by the physician, the trust and support from
his family and eventually a psychotherapeu-
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tic process aimed to the acceptance of the
disease.
Another point regards the topics on
which the patients would express their pre-
mature will. During the disease decisions to
be taken are many, diluted over time, having
a strong influence on quality of life. Not to
mention the emotional impact of patients
who might no longer be able to modify their
will due to advancing cognitive decline.
To at least partially overcome these
problems, the appointment of a health care
proxy could be a useful proposal. This per-
son would be chosen by the patient and
should be well informed about his/her med-
ical history. Generally the one pointed as
proxy is a member of family or anyway a
person in whom the patient places the
utmost confidence in order to interpret
his/her will when he/her will no longer be
able to fulfill it. This health care figure
should be proposed not simply when a diag-
nosis of dementia is made by the physician,
but rather after mental capacity of the
patient has been fully assessed. In fact,
while on the one hand it is true that people
with dementia have a higher risk of
impaired abilities than non-affected, on the
other hand a diagnosis of dementia by itself
does not necessarily mean that a person has
lost his capacity to self-determination.8
The questions which have been
described however clash with several socio-
politic realities not yet ready to meet with
these needs. Italy, for instance, is a sensitive
country though divided between secularism
and religion. A recent national report9 point-
ed a prevalence of almost one million indi-
viduals affected by dementia. The Italian
Government still tries to reach the solution
of these complex issues. However, the right
to health10 enshrined in the Constitution
lends itself to several interpretations. 
There are currently no specific guide-
lines on the national territory regarding
whether to draw up a living will by a patient
with dementia, neither about the informa-
tive role of physicians during the progres-
sive story of the disease.
Conclusions
In conclusion, for an adequate health
care planning, even in dementia, it is our
opinion that the writing of a living will
should be proposed to the patients in the
early days of their medical care. The need to
improve the quality of life of patients with
dementia goes also hand in hand with recent
scientific findings11,12 showing that subtle
changes or preclinical disabilities may
affect daily autonomy even in presence of a
mild cognitive decline. 
In this context, shared bioethical guide-
lines are necessary13 so that physicians who
deal with patients affected by dementia
should discuss every implication as soon as
possible after a diagnosis is reached.
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